| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,564 |
7,936 |
$401K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,855 |
3,339 |
$183K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,569 |
4,265 |
$105K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,335 |
1,303 |
$71K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,680 |
2,564 |
$54K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
909 |
843 |
$45K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
956 |
866 |
$37K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
583 |
570 |
$30K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,187 |
1,992 |
$26K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
426 |
403 |
$26K |
| 90461 |
|
1,387 |
1,340 |
$19K |
| 90671 |
|
86 |
80 |
$17K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
280 |
273 |
$15K |
| 90677 |
|
75 |
71 |
$14K |
| 90674 |
|
572 |
544 |
$14K |
| 90619 |
|
101 |
95 |
$12K |
| 90651 |
|
234 |
207 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
921 |
419 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
243 |
221 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
307 |
272 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
232 |
184 |
$8K |
| 86580 |
|
988 |
939 |
$5K |
| 99384 |
|
65 |
63 |
$4K |
| 99050 |
|
1,045 |
940 |
$4K |
| 90670 |
|
272 |
248 |
$4K |
| 90716 |
|
127 |
122 |
$3K |
| 97802 |
|
1,757 |
1,666 |
$3K |
| 99401 |
|
154 |
134 |
$3K |
| 99383 |
|
42 |
39 |
$2K |
| 96127 |
|
715 |
688 |
$2K |
| 90633 |
|
424 |
394 |
$2K |
| 3008F |
|
1,646 |
1,502 |
$1K |
| 99205 |
Prolong outpt/office vis |
14 |
14 |
$1K |
| 96160 |
|
558 |
550 |
$1K |
| 99173 |
|
1,578 |
1,399 |
$1K |
| 90707 |
|
133 |
114 |
$1K |
| 90700 |
|
182 |
172 |
$669.48 |
| 99051 |
|
428 |
397 |
$651.33 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
61 |
60 |
$498.16 |
| 90686 |
|
549 |
470 |
$419.38 |
| 90685 |
|
19 |
18 |
$377.79 |
| 90688 |
|
194 |
182 |
$294.45 |
| 90621 |
|
12 |
12 |
$292.80 |
| 90696 |
|
13 |
13 |
$245.14 |
| 90648 |
|
222 |
194 |
$238.57 |
| 90713 |
|
40 |
38 |
$183.46 |
| 90680 |
|
103 |
100 |
$181.83 |
| 90715 |
|
14 |
14 |
$148.21 |
| 90698 |
|
15 |
15 |
$111.30 |
| 90661 |
|
25 |
25 |
$97.35 |
| 90656 |
|
37 |
36 |
$61.32 |
| 99072 |
|
360 |
315 |
$52.50 |
| 99058 |
|
59 |
52 |
$40.00 |
| 99000 |
|
1,174 |
1,093 |
$37.95 |
| 91300 |
|
19 |
12 |
$8.00 |
| 90734 |
|
16 |
16 |
$0.00 |